Concepedia

Huifang Li

HL

Statistics

Publications

46

Citations

1.7K

H-Index

24

Active since

2008

Affiliations

University of British Columbia(Current)

University of Rhode Island

Sichuan University

First Affiliated Hospital of Kunming Medical University

West China Hospital of Sichuan University

Huifang Li is an author at University of British Columbia specializing in pharmacology, medicine, and life sciences.

ORCID

Publications per year

2008–2024

46

Publications

46

Targeted Therapy for <i>BRAFV600E</i> Malignant Astrocytoma

Theodore Nicolaides, Huifang Li, David A. Solomon et al. · Clinical Cancer Research · 2011 · 150 citations · Full text

, , +17

Discovery of Small-Molecule Inhibitors Selectively Targeting the DNA-Binding Domain of the Human Androgen Receptor

Huifang Li, Fuqiang Ban, Kush Dalal et al. · Journal of Medicinal Chemistry · 2014 · 119 citations · Full text

, , +17

Cdk5 Suppresses the Neuronal Cell Cycle by Disrupting the E2F1–DP1 Complex

Jie Zhang, Huifang Li, Odessa Yabut et al. · Journal of Neuroscience · 2010 · 97 citations · Full text

, , +17

Targeting the Binding Function 3 (BF3) Site of the Androgen Receptor Through Virtual Screening. 2. Development of 2-((2-phenoxyethyl) thio)-1<i>H</i>-benzimidazole Derivatives

Ravi S. N. Munuganti, Eric Leblanc, Peter Axerio-Cilies et al. · Journal of Medicinal Chemistry · 2013 · 89 citations · Full text

, , +17

PD-1-mediated inhibition of T cell activation: Mechanisms and strategies for cancer combination immunotherapy

Rui Liu, Huifang Li, Shu Li · Cell Insight · 2024 · 80 citations · Full text

, , +17

1–5 of 46